title: Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
authors.affiliation: Department of Dermatology, C/Saint Antoni Maria Claret 167, 08025 Barcelona, Spain. alopexfe@santpau.cat.
authors.forename: Anna
authors.initials: A
authors.lastname: López-Ferrer
authors.forename: Joan
authors.initials: J
authors.lastname: Dalmau
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Fernández-Figueras
authors.forename: Lluís
authors.initials: L
authors.lastname: Puig
mesh_terms: D017255:Acitretin / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D000069285:Infliximab; D007641:Keratolytic Agents / Q000627:therapeutic use*; D055623:Keratosis, Actinic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy / Q000009:adverse effects*; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007641:Keratolytic Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D017255:Acitretin; D000068800:Etanercept